Cargando…
Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773992/ https://www.ncbi.nlm.nih.gov/pubmed/24073010 http://dx.doi.org/10.1155/2013/838651 |
_version_ | 1782284452884381696 |
---|---|
author | Hsieh, Chen-Hsi Chao, K. S. Clifford Liao, Hui-Fen Chen, Yu-Jen |
author_facet | Hsieh, Chen-Hsi Chao, K. S. Clifford Liao, Hui-Fen Chen, Yu-Jen |
author_sort | Hsieh, Chen-Hsi |
collection | PubMed |
description | Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis. Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells. The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters. There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle (Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition. We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD. This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence. |
format | Online Article Text |
id | pubmed-3773992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37739922013-09-26 Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells Hsieh, Chen-Hsi Chao, K. S. Clifford Liao, Hui-Fen Chen, Yu-Jen Evid Based Complement Alternat Med Review Article Cancer stem cells (CSCs) existing in human cancers have been demonstrated to be a major cause of cancer treatment resistance, invasion, metastasis, and relapse. Self-renewal pathways, Wnt/β-catenin, Sonic hedgehog (Shh), and the Notch signaling pathway play critical roles in developing CSCs and lead to angiogenesis, migration, invasion, and metastasis. Multidrug resistance (MDR) is an unfavorable factor causing the failure of treatments against cancer cells. The most important and thoroughly studied mechanism involved in MDR is the active efflux of chemotherapeutic agents through membrane drug transporters. There is growing evidence that Norcantharidin (NCTD), a water-soluble synthetic small molecule derivative of naturally occurring cantharidin from the medicinal insect blister beetle (Mylabris phalerata Pallas), is capable of chemoprevention and tumor inhibition. We summarize investigations into the modulation of self-renewal pathways and MDR in CSCs by NCTD. This review may aid in further investigation of using NCTD to develop more effective strategies for cancer treatment to reduce resistance and recurrence. Hindawi Publishing Corporation 2013 2013-09-02 /pmc/articles/PMC3773992/ /pubmed/24073010 http://dx.doi.org/10.1155/2013/838651 Text en Copyright © 2013 Chen-Hsi Hsieh et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Hsieh, Chen-Hsi Chao, K. S. Clifford Liao, Hui-Fen Chen, Yu-Jen Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title | Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title_full | Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title_fullStr | Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title_full_unstemmed | Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title_short | Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells |
title_sort | norcantharidin, derivative of cantharidin, for cancer stem cells |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773992/ https://www.ncbi.nlm.nih.gov/pubmed/24073010 http://dx.doi.org/10.1155/2013/838651 |
work_keys_str_mv | AT hsiehchenhsi norcantharidinderivativeofcantharidinforcancerstemcells AT chaoksclifford norcantharidinderivativeofcantharidinforcancerstemcells AT liaohuifen norcantharidinderivativeofcantharidinforcancerstemcells AT chenyujen norcantharidinderivativeofcantharidinforcancerstemcells |